Haematologica
(Dec 2019)
The role of nuclear receptor co-activator 4 in erythropoiesis (Reply to Nai et al.)
- Naiara Santana-Codina,
- Sebastian Gableske,
- Mark D. Fleming,
- J. Wade Harper,
- Alec C. Kimmelman,
- Joseph D. Mancias
Affiliations
- Naiara Santana-Codina
- Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA;
- Sebastian Gableske
- Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA;
- Mark D. Fleming
- Department of Pathology, Boston Children’s Hospital and Harvard Medical School, 320 Longwood Avenue, Boston, MA
- J. Wade Harper
- Department of Cell Biology, Harvard Medical School, Boston, MA and
- Alec C. Kimmelman
- Department of Radiation Oncology, Perlmutter Cancer Center, New York University School of Medicine, New York, NY, USA
- Joseph D. Mancias
- Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA;
- DOI
-
https://doi.org/10.3324/haematol.2019.235226
- Journal volume & issue
-
Vol. 104,
no. 12
WeChat QR code